Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Nikan2 Holding ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   2.4% 7.4% 2.1% 6.1% 3.8% 3.8% 5.0% 5.0%   Credit score (0-100)   65 34 67 37 50 50 44 44   Credit rating   BBB BBB A BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -18.5 -186 -142 -233 -157 -220 0.0 0.0   EBITDA   -1,194 -1,344 -1,579 -1,705 -1,405 -1,470 0.0 0.0   EBIT   -1,603 -3,177 -1,896 -2,077 -1,954 -2,162 0.0 0.0   Pre-tax profit (PTP)   1,283.8 -192.5 3,864.6 -2,781.3 356.6 638.4 0.0 0.0   Net earnings   976.0 -494.5 3,013.8 -2,169.4 290.0 494.1 0.0 0.0   Pre-tax profit without non-rec. items   1,284 -192 3,865 -2,781 357 638 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   7,515 5,788 465 760 2,292 1,744 0.0 0.0   Shareholders equity total   8,242 7,694 10,597 8,314 8,490 8,866 8,664 8,664   Interest-bearing liabilities   900 858 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   15,160 15,156 17,736 14,597 14,984 15,506 8,664 8,664   Net Debt   -3,956 -5,888 -14,587 -9,669 -8,572 -9,422 -7,089 -7,089     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -18.5 -186 -142 -233 -157 -220 0.0 0.0   Gross profit growth   83.6% -905.6% 23.7% -63.6% 32.5% -40.0% 0.0% 0.0%   Employees   1 1 0 1 1 1 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   15,160 15,156 17,736 14,597 14,984 15,506 8,664 8,664   Balance sheet change%   7.6% -0.0% 17.0% -17.7% 2.7% 3.5% -44.1% 0.0%   Added value   -1,194.1 -1,344.4 -1,578.8 -1,705.4 -1,582.2 -1,470.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,047 -3,665 -5,745 590 839 -1,384 -1,744 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8,659.9% 1,706.2% 1,334.2% 893.3% 1,244.4% 984.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.2% 2.4% 27.3% 9.1% 6.3% 8.1% 0.0% 0.0%   ROI %   21.0% 3.9% 45.4% 15.4% 11.1% 14.3% 0.0% 0.0%   ROE %   12.5% -6.2% 33.0% -22.9% 3.5% 5.7% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   57.3% 50.8% 59.7% 57.0% 56.7% 57.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   331.3% 438.0% 923.9% 567.0% 610.2% 640.7% 0.0% 0.0%   Gearing %   10.9% 11.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   62.5% 62.5% 145.2% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.1 1.3 2.3 1.8 1.6 1.6 0.0 0.0   Current Ratio   1.1 1.3 2.3 1.9 1.7 1.8 0.0 0.0   Cash and cash equivalent   4,855.2 6,746.2 14,587.4 9,669.1 8,572.4 9,421.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,145.6 -3,410.8 -4,839.1 6.0 -3,502.0 -3,463.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -1,194 -1,344 0 -1,705 -1,582 -1,470 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -1,194 -1,344 0 -1,705 -1,405 -1,470 0 0   EBIT / employee   -1,603 -3,177 0 -2,077 -1,954 -2,162 0 0   Net earnings / employee   976 -495 0 -2,169 290 494 0 0